Business · 10/07/2019Updated: 10/17/2026 · 1 min read
Apotex, Inc. Sees FDA Withdraw Approval of 31 ANDA Applications
Summary
The FDA is withdrawing the approval of 31 abbreviated new drug applications submitted by Apotex, Inc., following a request from the company to withdraw the applications and waive a hearing.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →